Abstract
Background and aims: Hypertension (HTN) represents a significant global health concern associated with severe complications, including cardiovascular diseases, stroke, and kidney failure. Effective management and patient satisfaction with treatment are crucial for controlling the condition and preventing premature mortality. This cross-sectional study evaluated factors influencing treatment satisfaction among 319 hypertensive patients across 50 primary healthcare centers in Kerman, Iran, during January and February 2021.
Methods: This cross-sectional study focused on patients with HTN who were referred to fifty primary healthcare institutions in Kerman, southeast Iran, between January and February 2021. The 14-item Treatment Satisfaction Questionnaire for Medication (TSQM-14) and the 8-item Morisky Medication Adherence Scale were utilized to evaluate treatment satisfaction and medication adherence, respectively. Bivariate and multiple linear regression models were employed to identify factors associated with treatment satisfaction, which was scored on a scale from 0 to 100, reporting beta coefficients (B) and 95% confidence intervals (CI).
Results: In this study, participants with HTN had a mean age of 56.7±13 years. Overall, the average treatment satisfaction among respondents was 61.1±15.0. In the multiple regression model, treatment satisfaction was significantly associated with having a diagnosis of HTN for more than a decade (B=4.9; 95% CI: 1.3-8.6), measuring blood pressure (BP) more than eight times per month (B=8.3; 95% CI: 4.1-12.4), achieving controlled BP (B=6.5; 95% CI: 2.9-10.0), and adhering to treatment (B=5.6; 95% CI: 2.4-8.8).
Conclusion: Treatment satisfaction among hypertensive patients is currently suboptimal. Enhancing BP monitoring and medication adherence through targeted interventions has the potential to improve patient satisfaction and promote better long-term health outcomes.